Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cinnamomum burmannii, commonly known as Indonesian cinnamon, has been studied for its antimicrobial properties, lending some scientific support to its use as an alternative or adjunct to antibiotics. Laboratory studies have demonstrated that extracts and essential oils from C. burmannii possess activity against a range of bacteria, including Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The bioactive components, notably cinnamaldehyde, are believed to disrupt bacterial cell walls and inhibit growth.

Despite these promising in vitro (test tube) results, there is currently limited clinical evidence supporting the use of C. burmannii as a direct replacement for antibiotics in human infections. Most of the supporting research is preclinical, and there are few, if any, high-quality human trials assessing its efficacy for treating infections. Traditional use of cinnamon in various cultures has included applications for infections and general health, but C. burmannii specifically is less documented in this regard compared to other cinnamon species.

In summary, while there is some scientific rationale and preliminary evidence for the antimicrobial properties of C. burmannii, the overall strength of evidence is low (rated 2 out of 5). It should not be considered a stand-alone antibiotic alternative in clinical settings, but its components may have a role as adjuncts or in the development of new antimicrobial agents. Further research, particularly well-designed clinical trials, is needed to establish its efficacy and safety for this purpose.

More about Cinnamonum burmannii
More about Antibiotics (alternatives to)

Other ingredients used for Antibiotics (alternatives to)

Other health conditions supported by Cinnamonum burmannii

Products containing Cinnamonum burmannii